Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Astrocytoma 8Glioblastoma 5Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Recurrence 3Prostatic Neoplasms 3Lung Neoplasms 3Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurofibroma 1Neuroblastoma 1

Interventions

Cyclophosphamide 12Etoposide 11Granulocyte Colony-Stimulating Factor 7Filgrastim 7Carboplatin 7etoposide phosphate 6Vincristine 5Methotrexate 5Cisplatin 5fludarabine 4Topotecan 4Thiotepa 4Stem Cell Transplantation 4Radiotherapy 4Mesna 4Melphalan 4Temozolomide 3Sirolimus 3Ifosfamide 3Busulfan 3Automobiles 3selinexor 2sargramostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Leucovorin 2Ipilimumab 2Hydrocortisone 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rhabdoid Tumor × antineoplaston AS 2-1 × Clear all
NCT00003469 2017-08-24

Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

Burzynski Research Institute

Phase 2 Terminated
4 enrolled 6 charts

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡